source
- China clamps down on investigator-initiated biotech trials after patient deaths, halting rare-disease studiesChinese regulators have introduced new rules that sharply limit investigator‑initiated biotech trials after a series of patient deaths were reported this summer. The policy shift is intended to tig…
- One in Five Biopharma Workers Have Been Laid Off Multiple Times, Survey ShowsA recent BioSpace LinkedIn poll found that 64% of biotech and pharma professionals have been laid off in the past five years, and 22% have experienced job loss at least twice. Those who have faced…